Latest Capital Raises News

Equinox Resources has secured A$3 million to push forward its critical mineral projects, including a high-grade titanium discovery in Brazil, while navigating a significant legal challenge over Aboriginal heritage at its Hamersley Iron Ore Project.

Olympio Metals reports promising visible gold intersections at its Bousquet Gold Project and extensive copper mineralisation at Dufay, backed by a $1.5 million capital raise to advance exploration.

NH3 Clean Energy has made significant strides in its flagship WAH2 low-emission ammonia project, signing pivotal agreements on carbon capture and ammonia bunkering while strengthening its financial position.

Mont Royal Resources reported a net cash outflow in Q2 2025 driven by one-off merger expenses, while outlining plans for a capital raising to support ongoing operations.

Mont Royal Resources is progressing its merger with Commerce Resources to create a dual-listed Canadian critical metals developer, combining rare earth and lithium assets in Quebec.

Openn Negotiation Limited reported a $245k net cash outflow from operations in Q1 2025, offset partially by $211k in financing activities, leaving the company with just $6k in cash. The company depends on interest-free loans from its major shareholder to sustain operations amid limited liquidity.

Zimi Limited has completed production of its Smoke Connect safety range, progressed Matter Connect certification, and moved Senoa manufacturing to a new facility, while engaging investors for a capital raise.

4DS Memory Limited reports mixed progress in its June 2025 quarter, with ongoing root cause analysis into unexpected wafer test results and a stable cash position of $10.2 million.

First Au Limited has consolidated its flagship Victorian Goldfields Project with 100% ownership and is aggressively advancing its Nimba Gold Project in Liberia, supported by a $1.5 million capital raise and new drilling programs.

Mindax Limited reported a net cash outflow from operations of A$516,000 for the June quarter, ending with A$1.3 million in cash and recently secured an additional A$1.6 million through a share placement.

Zelira Therapeutics reports promising diabetic neuropathy study results with ZLT-L-007 surpassing Lyrica, while converting $3.25 million in notes to equity to bolster HOPE® 1 clinical development.

Assetora Limited has strengthened its financial footing with over two quarters of funding and secured a pivotal role as Responsible Entity of the DomaCom Fund, alongside a strategic $700 million mortgage management agreement.